Inventor · disambiguated record
James Cassella
Also filed as: CASSELLA JAMES · CASSELLA JAMES V
13 granted patents·11 pending applications·63 citations·filing 2000–2025
90Inventor score
Files withALEXZA PHARMACEUTICALS INC11SUN PHARMACEUTICAL IND INC8NEUROGEN CORP2CONCERT PHARMACEUTICALS INC1PFIZER1
Top patents by PatentIndex Score
24 records- 0195US9724341B2Nicotine salt with meta-salicylic acidALEXZA PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·22 cites·2 claims
- 0293US10166224B2Nicotine salt with meta-salicylic acid and applications thereinALEXZA PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·11 cites·3 claims
- 0392US12285432B2Treatment of hair loss disorders with deuterated JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2023·Granted Apr 29, 2025·2 cites·28 claims
- 0489US11717479B2Method of treating epilepsyALEXZA PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·2 cites·37 claims
- 0589US11241383B2Method of treating epilepsyALEXZA PHARMACEUTICALS INC·Filed 2017·Granted Feb 8, 2022·6 cites·35 claims
- 0686US10561659B2Treatment of hair loss disorders with deuterated JAK inhibitorsCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·9 cites·21 claims
- 0784US12364699B2Method of treating hair loss disordersSUN PHARMACEUTICAL IND INC·Filed 2024·Granted Jul 22, 2025·1 cites·30 claims
- 0883US12076323B2Treatment of hair loss disorders with deuterated JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2019·Granted Sep 3, 2024·2 cites·29 claims
- 0980US2025032407A1Method of treating epilepsyALEXZA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1079US11511054B2Use of antistatic materials in the airway for thermal aerosol condensation processALEXZA PHARMACEUTICALS INC·Filed 2016·Granted Nov 29, 2022·4 cites·16 claims
- 1177US2022401431A1Nicotine salt with meta-salicylic acid and applications thereinALEXZA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1275US12133915B2Method of treating epilepsyALEXZA PHARMACEUTICALS INC·Filed 2022·Granted Nov 5, 2024·0 cites·34 claims
- 1375US2024423986A1Treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1473US11458130B2Nicotine salt with meta-salicylic acid and applications thereinALEXZA PHARMACEUTICALS INC·Filed 2018·Granted Oct 4, 2022·0 cites·9 claims
- 1566US2025114367A1Method of treating hair loss disordersSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1662US2025275979A1Treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 1761US2025275977A1Dosage regimens for treatment with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2023·Application pending·0 cites
- 1860US6737242B1Methods for screening GABA-modulatory compounds for specified pharmacological activitiesNEUROGEN CORP·Filed 2000·Granted May 18, 2004·4 cites·12 claims
- 1957US2016324845A1Nicotine salt with meta-salicylic acid and applications thereinALEXZA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2057US2023390292A1Regimens for the treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2021·Application pending·0 cites
- 2156US2021052830A1Use of antistatic materials in the airway for thermal aerosol condensation processALEXZA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2252US2005009861A1Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disordersPFIZER·Filed 2004·Application pending·0 cites
- 2344US7060451B2Methods for screening GABA-modulatory compounds for specified pharmacological activitiesNEUROGEN CORP·Filed 2001·Granted Jun 13, 2006·0 cites·21 claims
- 2444US2002151591A1Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disordersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Cassella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →